| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:olaratumab
CAS:1024603-93-7
Remarks:Olaratumab is a monoclonal antibody used for the treatment of solid tumors. In combination with doxorubicin, it can be used for the treatment of adults with advanced soft-tissue sarcoma (STS) who cann
|
| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
17754423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:Olaratumab
CAS:1024603-93-7
Purity:95% Package:100ug;500ug;1mg
|
| Company Name: |
Guangzhou Hongyuan Chemical Co.,Ltd
|
| Tel: |
15817493340 |
| Email: |
981810490@qq.com |
| Products Intro: |
Product Name:Olaratumab
CAS:1024603-93-7
Purity:95% Package:1mg;1g;100g
|
|
| | Olaratumab Basic information |
| Product Name: | Olaratumab | | Synonyms: | Olaratumab;Research Grade Olaratumab(DHD16101);IMC 3G3;IMC3G3;IMC-3G3;Lartruvo;LY 3012207;LY3012207 | | CAS: | 1024603-93-7 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Olaratumab Structure]() |
| | Olaratumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Olaratumab Usage And Synthesis |
| Clinical Use | Monoclonal antibody:
Treatment of advanced soft tissue sarcoma in
combination with doxorubicin | | Drug interactions | Potentially hazardous interactions with other drugs
Live vaccines: avoid with olaratumab in combination
with doxorubicin. | | Metabolism | Mainly degraded non-specifically by proteolytic enzymes. |
| | Olaratumab Preparation Products And Raw materials |
|